[HTML][HTML] Systematic genomic and clinical analysis of severe acute respiratory syndrome coronavirus 2 reinfections and recurrences involving the same strain

C Rodríguez-Grande, L Alcalá, A Estévez… - Emerging Infectious …, 2022 - ncbi.nlm.nih.gov
Estimates of the burden of severe acute respiratory syndrome coronavirus 2 reinfections are
limited by the scarcity of population-level studies incorporating genomic support. We …

Assessing asymptomatic, presymptomatic, and symptomatic transmission risk of severe acute respiratory syndrome coronavirus 2

P Wu, F Liu, Z Chang, Y Lin, M Ren… - Clinical Infectious …, 2021 - academic.oup.com
Background The relative contributions of asymptomatic, presymptomatic, and symptomatic
transmission of severe acute respiratory syndrome coronavirus 2 have not been clearly …

An update on severe acute respiratory syndrome coronavirus 2 diversity in the US national capital region: evolution of novel and variants of concern

CP Morris, CH Luo, A Amadi, M Schwartz… - Clinical Infectious …, 2022 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
concerning for enhanced transmission, evasion of immune responses, or associated with …

Severe acute respiratory syndrome coronavirus 2 lethality did not change over time in two Italian provinces

ME Flacco, C Acuti Martellucci, F Bravi… - Open Forum …, 2020 - academic.oup.com
This retrospective cohort study included all the subjects diagnosed with severe acute
respiratory syndrome coronavirus 2 infection (n= 2493) in 2 Italian provinces. Two hundred …

[HTML][HTML] Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based …

M Poljak, AO Valenčak, E Štrumbelj, PM Vodičar… - Clinical Microbiology …, 2021 - Elsevier
Objectives Seroprevalence surveys provide crucial information on cumulative severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. This Slovenian nationwide …

Severe acute respiratory syndrome coronavirus 2 incidence and risk factors in a national, community-based prospective cohort of US adults

D Nash, MS Rane, MKM Robertson… - Clinical Infectious …, 2023 - academic.oup.com
Background Prospective cohort studies of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) incidence complement case-based surveillance and cross-sectional …

Severe acute respiratory syndrome coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity …

EC Hughes, JAR Amat, J Haney, YA Parr… - The Journal of …, 2021 - academic.oup.com
Identifying drivers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exposure and quantifying population immunity is crucial to prepare for future epidemics. We …

[HTML][HTML] Large-scale testing of asymptomatic healthcare personnel for severe acute respiratory syndrome coronavirus 2

CA Hogan, S Gombar, H Wang, K Röltgen… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
Abstract Large-scale, 1-time testing of> 12,000 asymptomatic healthcare personnel in
California, USA, during April–June 2020 showed that prevalence of severe acute respiratory …

Infection prevention and control of severe acute respiratory syndrome coronavirus 2 in health care settings

ML Winkler, DC Hooper, ES Shenoy - Infectious Disease Clinics, 2022 - id.theclinics.com
Infection Prevention and Control of Severe Acute Respiratory Syndrome Coronavirus 2 in
Health Care Settings - Infectious Disease Clinics Skip to Main Content Skip to Main Menu …

Comparison of estimated severe acute respiratory syndrome coronavirus 2 seroprevalence through commercial laboratory residual sera testing and a community …

KL Bajema, FS Dahlgren, TW Lim… - Clinical Infectious …, 2021 - academic.oup.com
We compared severe acute respiratory syndrome coronavirus 2 seroprevalence estimated
from commercial laboratory residual sera and a community household survey in …